BIM-018

BIM-018 is a synthetic cannabinoid that is structurally related to JWH-018, which is known for its potent psychoactive effects. BIM-018 is a full agonist at both the CB1 and CB2 cannabinoid receptors, with a binding affinity of 1.2 nM at CB1 and 1.1 nM at CB2. It is one of the few synthetic cannabinoids to have been studied in animals, with studies showing it to have similar effects to THC, the main active component of cannabis.

Chemistry[edit | edit source]

BIM-018 is a derivative of JWH-018, with a phenylacetyl group replacing the naphthyl group of JWH-018. This change in structure results in a compound with similar binding affinity to the cannabinoid receptors, but with a different chemical structure. The exact synthesis of BIM-018 is not publicly available, but it is likely to involve a similar process to the synthesis of JWH-018, involving the reaction of a suitable phenylacetyl halide with a suitable indole derivative.

Pharmacology[edit | edit source]

BIM-018 acts as a full agonist at both the CB1 and CB2 cannabinoid receptors, with a slightly higher affinity for the CB1 receptor. This is similar to the action of THC, which is also a full agonist at both receptors. The psychoactive effects of BIM-018 are likely to be due to its action at the CB1 receptor, which is primarily located in the brain. The CB2 receptor is primarily located in the immune system, and the effects of BIM-018 at this receptor are less well understood.

Effects[edit | edit source]

The effects of BIM-018 are similar to those of THC and other synthetic cannabinoids, and include euphoria, relaxation, and changes in perception. However, as with all synthetic cannabinoids, the effects can be unpredictable and can vary greatly between individuals. There have been reports of severe adverse effects, including psychosis, seizures, and cardiac arrest, particularly when BIM-018 is used in high doses or in combination with other substances.

Legal Status[edit | edit source]

The legal status of BIM-018 varies by country. In many countries, including the United States, it is classified as a Schedule I controlled substance, making it illegal to manufacture, distribute, or possess. In other countries, it may be legal or regulated under analogue laws.

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Translate this page: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.